Ontology highlight
ABSTRACT:
INSTRUMENT(S): 6330 Ion Trap LC/MS
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Cerebrospinal Fluid
DISEASE(S): Lewy Body Dementia,Alzheimer's Disease,Memory Impairment
SUBMITTER: Homira Behbahani
LAB HEAD: Homira Behbahani
PROVIDER: PXD010230 | Pride | 2018-08-13
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
Homira 3sep21.pride.mgf.gz | Mgf | |||
Homira18Oprov1.mgf | Mgf | |||
Homira18Oprov1.pride.mgf.gz | Mgf | |||
Homira18Oprov2.Aug3mgf.mgf | Mgf | |||
Homira18Oprov2.Aug3mgf.pride.mgf.gz | Mgf |
Items per page: 5 1 - 5 of 45 |
Eriksdotter Maria M Navarro-Oviedo Manuel M Mitra Sumonto S Wahlberg Lars L Linderoth Bengt B Tjernberg Lars O LO Behbahani Homira H
Experimental cell research 20180806 1
Alzheimer's disease (AD) is characterized by early degeneration of cholinergic neurons and decreased levels of nerve growth factor (NGF). Thus, increasing the NGF levels by for instance encapsulated cell bio-delivery (ECB) is a potential treatment strategy. The results from our previous first-in-human studies on ECB of NGF to the basal forebrain cholinergic neurons were promising, but indicated some variability of long-term viability of the encapsulated cells and associated reduced NGF-release. ...[more]